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In HCT116 colorectal cancer cells, HeLa cervical cancer cells and HuH-7 hepatoma cells, miR-223 is
expressed at a low level. Through infection with lentivirus containing miR-223 precursor, miR-233
was overexpressed in all these cells. Interestingly, the expression levels of FOXO1mRNA and protein,
and phosphorylation levels became signiﬁcantly lower than those of their control. FOXO1 was
down-regulated mainly in the cytoplasm, while the nuclear FOXO1 level became relatively high
compared to the cytoplasm. As the unphosphorylated active form of FOXO1 increased in the cells,
cyclin D1/p21/p27 were up-regulated at either mRNA or protein level. Proliferation of the cells
was also greatly inhibited when miR-223 was over-expressed. Therein, our data suggest that miR-
223 regulates FOXO1 expression and cell proliferation.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Forkhead box O (FOXO) transcription factors FOXO1, FOXO3a,
FOXO4 and FOXO6, the mammalian orthologs of Caenorhabditis
elegans DAF-16, are emerging as an important family of proteins
that modulate the expression of many important genes involved
in apoptosis, autophagy, DNA damage repair, oxidative stress, cell
differentiation, cell cycle progression, and glucose metabolism
[1]. These FOXOs activate or repress multiple target gene expres-
sion involved in tumor suppression, such as Bim, Trail and Fas L
which induce apoptosis; p21, p27 and cyclin D1 in cell cycle regu-
lation; GADD45a in DNA damage repair and Atg7 in autophagy
[2,3]. Abnormal expression or activation of FOXO can result in dis-
orders of apoptotic pathways, proliferation, and cell cycle regula-
tion. In addition, some reports have revealed involvement of
FOXO1 in several cancer progression regulations. One of these re-
ports has showed that the loss of FOXO1A through chromosomal
deletion (13q14) is observed in prostate cancers, and can promote
tumorigenesis and progression to androgen independently [4].
Samuels and colleagues demonstrated that PI3 kinase inhibitorchemical Societies. Published by E
of Children Health Care, Yu
Shan College Zone, Wenzhou
istry and Molecular Biology,
i Xue Yuan Road, Shanghai
@shmu.edu.cn (X.Z. Wu).
ually as the ﬁrst author.LY294002 slightly inhibits FOXO1 and FOXO3 phosphorylation,
but reduces greatly the proliferation of HCT116 and DLD1 colorec-
tal cancer cells [5]. Human leukemia cells HL-60AR in which PI3K/
Akt axis is constitutively activated, displayed higher levels of phos-
phorylated FOXO1 and FOXO3 than the parental HL-60 cells, and
the forkhead factors are localized predominantly in the cytoplasm.
Furthermore, HL-60AR cells proliferated faster than their parent
cells and show a lower amount of the cdk inhibitor p27Kip1, but
higher levels of cyclin D1 [6]. However, FOXO proteins are regu-
lated by multiple post-translational modiﬁcation mechanisms,
such as ubiquitination as well as phosphorylation [7]. These
post-translational modiﬁcations direct FOXO proteins to speciﬁc
sites in the cells. In the nucleus FOXO proteins control transcrip-
tional programs, while in the cytoplasm, FOXO proteins become
transcriptionally inactive after phosphorylation and undergo pro-
teasomal degradation after ubiquitination. FOXO1 can also be reg-
ulated by several microRNAs since the 30 untranslated region
contains several potential miRNA binding sites [8–10].
MiRNAs are small non-coding RNAs comprising of 20–22 nucle-
otides. They can silence target genes by interactingwithmRNAs and
result in mRNA degradation or translational repression [11]. Gener-
ally in proliferating cells miRNAs repress translation. Whereas in
G1/G0 arrest (which often precedes differentiation), they mediate
activation of translation [12]. However, their roles have been under-
lined inmany biologic processes, such as cell proliferation, differen-
tiation, and apoptosis, not only in development, but also in
oncogenesis [13,14]. Through informatics analysis we found that
there is a putative binding site in the 30 untranslated region (UTR)lsevier B.V. All rights reserved.
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cently investigated and observed an important role of miR-223 in
inhibition of cancer cell proliferation [15]. There is emerging evi-
dence suggests that miR-223 expression and maturation involve
in the regulation of cell proliferation, hematopoietic development
and differentiation [16–18]. Overexpression of miR-223 reduces
Fbw7 mRNA levels and increases endogenous cyclin E protein and
activity levels which lead to genomic instability [19,20]. MiR-223
is also repressed in hepatocellular carcinoma and potentiates the
expression of stathmin 1 [17]. Colorectal cancer HCT116 cells ex-
press very low levels of endogenous miR-223. In this study we took
an advantage of these cells to over-express or inhibit miR-223 and
investigate further the potential regulation of FOXO1 by miR-223.2. Materials and methods
2.1. Materials
Lentivirus plasmids pLL3.7 (EV) and pLL3.7-miR-223 (miR-223)
were constructed as our previous report [15]. PsiCHECK™-2-
FOXO1 30UTR was generated by cloning the 30-untranslated region
(30UTR) of FOXO1 mRNA into the 30 site of the renilla luciferase
gene in psiCHECK™-2 vector (Promega, Madison, WI, USA). Anti-
bodies against FOXO1 and phospho-FOXO1 were purchased from
Bioworld (Bioworld, Atlanta, Georgia 30305, USA). Antibodies
against cyclin D1, p21waf1, and p27kip1 were from Lab Vision Corpo-
ration (Thermo Fisher Scientiﬁc, Fremont, CA 94538, USA). MiR-
223 inhibitor was purchased from Gene Pharma (Shanghai, China).
2.2. Cell culture and transfection
Human colorectal carcinoma HCT116 cells and Human Embry-
onic Kidney HEK-293T cells were cultured in DMEM and NB4 cells
in RPMI-1640 supplemented with 10% fetal bovine serum and anti-
biotics (100 lg/ml penicillin and 100 U/ml streptomycin). Human
cervical cancer cells (HeLa) and hepatocellular carcinoma cells
(HuH-7) were maintained in DMEM supplemented with 10% new-
born calf serum and antibiotics (100 lg/ml penicillin and 100 U/ml
streptomycin). We referred to cells infected with the virus carrier
pLL3.7 as EV group and those with pLL3.7-miR223 as miR-223
group in the following experiments. All the cells were maintained
at 37 C with 5% CO2 and humidiﬁed atmosphere.
Transfection was carried out according to the manufacturer’s
instruction. Cells were seeded in 60 mm dishes for 24 h incubation
before transfection. Then cells were transfected using transfection
reagent (SunBio, Shanghai, China).
2.3. Dual luciferase reporter assay
HEK-293T cells were seeded in 96-well plates. After 24 h incu-
bation, cells were transfected with psiCHECK™-2-FOXO1 30UTR
and pLL3.7 or pLL3.7-miR-223. Forty-eight hours after transfection,
the cells were assayed by both ﬁreﬂy and renilla luciferase using
the dual luciferase assay system (Promega) according to manufac-
turer’s instructions. All transfection experiments were conducted
in triplicate and repeated 3 times independently.
2.4. Semi-quantitative RT-PCR and quantitative PCR
MiRNA measurement was according to our previous reports
[15,21]. Brieﬂy, harvested cells were treated with Trizol reagent
(DBI, Shanghai, China) for 5 min at room temperature, and then to-
tal RNA was extracted from the cells according to the manufac-
turer’s instruction. The cDNA strand was synthesized from 5 lg
of total RNA using oligo dT or speciﬁc reverse transcription primers(for RNU6 or miR-223). The expression levels of RNU6 and miR-223
were analyzed by PCR which consisted of 25 cycles of 94 C for
30 s, 55 C for 30 s, 72 C for 30 s, and ﬁnally 72 C for 10 min.
Quantitative PCR were performed with iQ5 Real-Time PCR detec-
tion system (Bio-Rad, Alfred Nobel Drive, Hercules, CA, USA).
2.5. Western blot
Western blotting was done with whole-cell extracts prepared
by lysing cells in 1% SDS and 1 mmol/l phenylmethanesulfonyl
ﬂuoride (PMSF) on ice for 15 min. After centrifugation, the super-
natant was used as protein source and the concentration of protein
was determined by Lorry’s method. A same amount of proteins was
loaded and resolved on SDS–PAGE, and electrotransferred onto a
polyvinylidene diﬂuoride membrane (Millipore, Bedford, MA,
USA). After blocking with 5% non-fat milk in PBST for 2 h at room
temperature, the blots were incubated with speciﬁc primary anti-
bodies against FOXO1, phosphorylated FOXO1, p21, p27, and cyclin
D1, respectively overnight. Then the blots were washed with PBST
for 3 times. The blots were detected using horseradish peroxidase-
linked anti-mouse or anti-rabbit immunoglobulin secondary anti-
body. The signal was detected by ECL after washing.
2.6. Immunocytochemistry
HCT116, HeLa, andHuH-7 cells were seeded onto chamber slides
and incubated for 24 h as our previous reports [22]. Seventy-two
hours post-transfection with control vector (EV) or miR-223 plas-
mid, cells were rinsed with PBS and ﬁxed by 4% paraformaldehyde
for 20 min at room temperature. After being permeated with 0.5%
Triton X-100 for 10 min, cells on the slide were blocked with 5%
sheep serum for 2 h at room temperature. The cells were then incu-
bated with rabbit polyclonal anti-FOXO1 antibody for 4 C over-
night. After washing and incubation with tetramethyl rhodamine
isothioeyanate (TRITC)-labeled goat anti-rabbit immunoglobulin
for 1 h at room temperature and DAPI for 10 min, the slides were
examined under a ﬂuorescent microscope. The positive FOXO1 pro-
tein was stained in the nuclei and cytoplasm. The ﬂuorescence
intensities were quantiﬁed with Image J software.
2.7. Acidic phosphatase assay
Cells were seeded on 96-well plates with a density of 1000 cells
per well for each kind of cell lines. After 24 h incubation, transient
transfection was performed. After transfection, the plates were
washed with PBS, and each well of the plates was added with
100 ll reaction solution (0.1 mol/l NaAc pH 5.0, 0.1% Triton X-
100, 5 mmol/l p-nitrophenyl phosphate) and incubated at 37 C
for 2 h. Then, the reaction was stopped by adding 10 ll 1 N NaOH
perwell and the absorbance at 405 over 630 nmwas read by a spec-
trophotometer. The activity of the acidic phosphatase represented
the number of survival cells tested as previous reports [23,24].
2.8. Flow cytometric analysis
The cell cycle was analyzed using a FACScalibur machine as our
previous reports [22,24].
2.9. Statistics
All experiments were conducted in triplicate and repeated at
least three times independently. The results of relative acidic phos-
phatase activity are expressed as the means ± standard error. Sta-
tistical analysis of the average value between 2 groups was done
by Student’s t-test, and differences with P value less than 0.05 were
considered statistical signiﬁcance.
Fig. 1. MiR-223 targets 30 untranslated region (UTR) of FOXO1 mRNA. (A) The sequence in the 30UTR of FOXO1 mRNA (positions 2736–2742 in gray) was predicted to bind
miR-223 seed sequence and is conserved in several species (Mml, Macaca mulatta; Hsa, Homo sapiens; Ptr, Pan troglodytes; Cpo, Cavia porcellus; Ocu, Oryctolagus cuniculus).
(B) Plasmid pLL3.7 or recombinant plasmid pLL3.7-miR-223 was co-transfected with psi-CHECK™-2-FOXO1 30UTR in HEK-293T cells. The relative activity of renilla/ﬁreﬂy
luciferase activity was signiﬁcantly decreased in the group of miR-223 as compared to the EV (pLL3.7) group.⁄⁄P < 0.01. (C) HeLa, HuH7, and HCT116 cells were transfected
with EV and miR-223 constructs respectively and miR-223 expression was measured by RT-PCR. EV group was transfected with pLL3.7, while miR-223 group was the cells
transfected with recombinant plasmid pLL3.7-miR-223. RNU6 was as endogenous control. (D) Western blot were conducted to detect the protein expression levels of FOXO1
and FOXO1-p (phosphorylated FOXO1). (E) Quantitative PCR was conducted to detect the mRNA expression levels of FOXO1. ⁄P < 0.05, ⁄⁄P < 0.01.
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3.1. FOXO1 is regulated by miR-223
Through the website Targetscan 5.1 analysis, we noted that
miR-223 had a potential binding site at the 30UTR of FOXO1 mRNA
(Fig. 1A). Therefore we constructed reporter plasmids containing
the 30UTR of FOXO1 mRNA to investigate the regulating effect by
miR-223. In order to observe the direct targeting by miR-223 on
FOXO1 mRNA, we co-transfected miR-223 with a luciferase con-
struct containing the FOXO1 3’UTR (psiCHECK™-2-FOXO1 30UTR).
The group transfected with miR-223 resulted in a signiﬁcant de-
crease in renilla luciferase activity (Fig. 1B), while the EV vector
did not express miR-223 and the renilla luciferase activity re-
mained at a high level. Then we established an overexpression cell
mode for miR-223 to further investigate the regulation. We noted
that miR-223 is expressed lowly in HuH7 and HCT116 cell lines in
several previous reports [17,19], but FOXO1 expressed highly. So
we transfected miR-223 construct into these cell lines. After trans-
fection, RT-PCR results showed that miR-223 was overexpressed in
all HeLa, HuH7, and HCT116 cell lines respectively (Fig. 1C). Inter-
estingly in these transfectants, both the mRNA and protein levels of
FOXO1 were signiﬁcantly down-regulated (Fig. 1D and E). Immu-
nocytochemistry results also demonstrated that FOXO1 was de-
creased in these miR-223 overexpressing cells (Fig. 2). The
phosphorylated FOXO1 level was also reduced in the groups with
overexpression of miR-223 (Fig. 1E). The phosphorylated FOXO1
is the inactive form and any alteration of FOXO1 phosphorylation
is closely linked to its regulation function.3.2. MiR-223 mainly down-regulates cytoplasm FOXO1
The subcellular localization of FOXO1 protein is important for its
activity and regulation function. The transcriptional activities of
FOXO1 require its accumulation in the nucleus and unphosphoryla-
tion for the downstream gene transcription regulation. Therefore,
we examined FOXO1 subcellular distribution using immunoﬂuo-
rescence after overexpression of miR-223 in these cells (Fig. 2).
Interestingly, miR-223 overexpression mainly reduced the cyto-
plasm FOXO1 protein, but not this in nucleus, and the amount of
the nuclear FOXO1 was relative high in miR-223-transfected cells
as compared to control (Fig. 2A and B). Similar results could be seen
in all HeLa, HuH7, and HCT116 cells.
3.3. Overexpression of miR-223 regulates FOXO1 downstream
molecules and cell proliferation
FOXO1 is involved in the control of cell proliferation as a puta-
tive tumor suppressor through regulation of its downstream mol-
ecule genes. In the miR-223-trasnfected HCT116 cells, both
mRNA and protein levels of the cell cycle regulators p21 and p27
were signiﬁcantly up-regulated (Fig. 3A and B), while cyclin D1
was sharply down-regulated (Fig. 3C) although miR-223 targeted
the cytoplasmic FOXO1mainly. Further in HuH7 and HeLa cells, cy-
clin D1 mRNA expression was also down regulated after miR-223
overexpression. The increasing expression levels of p21 and p27,
or the decreased cyclin D1 were coincident and consistent with
the cell growth retardation. The proliferation rate of HeLa, HuH7,
and HCT116 cells were signiﬁcantly slowed down as it was
Fig. 2. Cellular localization of FOXO1 in miR-223 overexpressing cancer cells. (A) HuH7, HeLa, and HCT116 cells were transfected with EV and miR-223 respectively and
stained with FOXO1 speciﬁc primary antibody and TRITC-conjugated secondary antibody (red). PLL3.7 contains GFP (green ﬂuorescent protein) gene which expresses green
ﬂuorescent signal. Cell nuclei were thus visualized by DAPI (blue). All cells were examined under an Olympus ﬂuorescent microscope with original magniﬁcation 40. All
images shown are representative images from three independent experiments. (B) The ﬂuorescence intensities in the cytoplasm (top panel), and nucleus (bottom panel) of
three cell lines were measured. The data shown are the means ± S.D. of 10 cells in 10 randomly selected ﬁelds. ⁄⁄P < 0.01, ⁄P < 0.05.
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HCT116 and HuH7 cells).
3.4. Retinoic acid regulates miR-223 and FOXO1
In above HuH7 and HCT116 cells, miR-223 is lowly expressed,
while the leukemic NB4 cells express high level of miR-223 and
the expressional level of FOXO1 is low. After NB4 cells were treated
with 1 lM retinoic acid for 48 h, the expression of miR-223 was
signiﬁcantly induced and the band of FOXO1 became fainter as
the RT-PCR results indicated (Fig. 4A). After retinoic acid treatment,
the growth of NB4 cells was signiﬁcantly inhibited and the cells at
G1 phase were signiﬁcantly accumulated and cells at S stage re-
duced signiﬁcantly (Fig. 4B). Much more post-mitotic cells (met-
amyelocytes, segmented neutrophils) were seen as our previous
reports [15,25] (data not shown here). However after treatment
with a miR-223 inhibitor which is a chemically modiﬁed comple-
mentary oligonucleotide with mature miR-223, the expression of
FOXO1 mRNA increased interestingly (Fig. 4C) and the cells prolif-
erated. Shorter time was needed for the passage in the cells treated
with miR-223 inhibitor than that of control. The cell population at
G2/M phase increased signiﬁcantly (Fig. 4D) although G1 and S
phases were not different between the inhibitor and control.
4. Discussion
Previous documents have reported that miR-223 can be in-
volved in a diversity of biologic roles as either a tumor suppressor
[17,26], or an oncogenic regulator. In esophageal carcinoma cells,
miR-223 targeted artemin (ARTN) and its overexpression repressed
cell migration and invasion [26]. However, in gastric cancer,miRNA-223 promoted invasion and metastasis by targeting tumor
suppressor EPB41L3 [27]. Our recent study [15] demonstrated that
miR-223 plays an important role in the inhibition of hepatoma cell
proliferation via targeting insulin-like growth factor-1 receptor
(IGF-1R). Our study also showed that the 30UTR of Rasa1 mRNA
was targeted by miR-223 directly. Rasa1, an important regulator
converting RAS-GTP to RAS-GDP, plays a negative role in prolifera-
tion regulation, but its downstream ERK1/2 was inhibited as the
IGF-1R was targeted and did not worked in the action of miR-
223. In current study, we observed that FOXO1mRNA was targeted
by miR-223 in 3 cancer cell lines. All of the results in these 3 cancer
cell lines showed a same phenomenon that miR-223 is expressed
in a low level, but FOXO1 is highly expressed. When these cells
were transfected with miR-223 construct and miR-223 was over-
expressed. In these cells with overexpression of miR-223, a re-
duced expression level of both FOXO1 mRNA and protein was
observed. In the reporter assay with the vector containing 30UTR
of FOXO1 mRNA, the relative renilla luciferase activity was greatly
inhibited by co-transfection of miR-223 construct. All these sug-
gested that miR-223 regulated FOXO1 mRNA. In NB4 cells that ex-
pressed a high level of miR-223, there was also an inverted
correlation between miR-223 and FOXO1 mRNA expressions.
FOXO1 is a member of FOX transcription factors O subfamily.
FOXO1 together with other members such as FOXO3, FOXO4 etc.,
participates in cell function regulations related to cell cycle exit
and arrest at G1, induction of apoptosis, oxidative and cellular
stress [28]. FOXO is characterized by a highly conserved forkhead
domain with a winged-helix motif and DNA-binding activity. This
domain possesses a transcription regulation activity for various
genes including p27Kip1, p130-Rb2, and cyclin D1/2 (cell-cycle reg-
ulation), tumor necrosis factor-related apoptosis-inducing ligand
Fig. 3. MiR-223 overexpression suppresses cell proliferation. (A) The expression levels of p21 and p27 were analyzed by quantitative PCR. ⁄⁄P < 0.01 ⁄P < 0.05. (B) The protein
levels of p21 and p27 were measured by Western blot. The protein levels of either p21 or p27 increased signiﬁcantly in miR-223 overexpressing HCT116 cells. (C) Cyclin D1
mRNA was detected by quantitative PCR in HeLa/HuH7/HCT116 cells. ⁄⁄P < 0.01. (D) Cell proliferation rate were analyzed and evaluated via acidic phosphatase activity which
represented the surviving cell number in the assay. This assay was performed in all HeLa, HuH7, and HCT116 cells. All these cell proliferation rates slowed down signiﬁcantly
in miR-223 group as compared to EV group. ⁄⁄P < 0.01.
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inhibitor p27, resulting in cell-cycle progression block at phase
G1 [4,29,30]. In epithelial cells it has been shown that Smads in-
crease p21 expression by forming a complex with FOXOs. The p21
promoter contains both FOXO and Smad enhancer elements, which
are both required for the induction of p21 expression by TGFb [31].
Nakae et al. have shown that in adipocytes insulin signaling re-
presses the level of p21 expression and results in increased prolifer-
ation, while in absence of insulin, FOXO1 activation results in anFig. 4. MiR-223 regulation of FOXO1 in NB4 cells. (A) NB4 cells were treated with retino
PCR. (B) NB4 cell cycles were analyzed by a ﬂow cytometer after retinoic acid treatment.
NB4 cells were incubated with 50 nM miR-223 inhibitor for 24 h and up regulation of FO
analyzed after treatment with 50 nM miR-223 inhibitor and comparison was made betwincrease in p21 expression and a cell cycle arrest [32]. Schmidt
et al. suggest that the effect of FOXO4 on proliferation also depends
on the repression of cyclin D expression and a decrease in cyclin D/
CDK activity [33].
The activity of FOXO1 requires its accumulation in the nucleus
and unphosphorylation which are important for the transcription
regulation of the downstream molecule genes as previously stated
[7]. Our data indicated that miR-223 could really target FOXO1
mRNA which led to reduction of cytoplasmic FOXO1 protein. Theic acid for 48 h. The expression levels of miR-223 and FOXO1 were measured by RT-
The data of cell cycle at G1 and S phase were statistically summarized. ⁄⁄P < 0.01. (C)
XO1 mRNA level was shown by RT-PCR analysis. (D) The cell cycle of NB4 cells was
een miR-223 inhibitor and control groups. ⁄P < 0.05.
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cence staining. However, the inactive form of phosphorylated
FOXO1 was also down-regulated after miR-223 overexpression
and thus the active form of unphosphorylated FOXO1 was then
up-regulated. As unphosphorylated FOXO1 increased, the protein
FOXO1 was apt to enter the nucleus. Therefore, the signal of FOXO1
immunoﬂuorescence staining was more concentrated in the nu-
cleus when cytoplasmic FOXO1 was targeted by miR-223. The roles
of miRNA-223 may oscillate between repression and activation in
coordinationwith other regulatorswhich catalyze the phosphoryla-
tion of FOXO1 and it also depends on the relative importance of tar-
getedmolecule in the regulation pathway such as IGF-1R and Rasa1.
High contents of miR-223 in esophageal squamous cell carcinoma
may have an adverse impact on the patient’s disease-free survival
[20] from the analysis of 109 resected specimens. The circulating
miR-223 is also signiﬁcantly higher in patients with human hepato-
carcinoma than those in healthy control [34] although it is appar-
ently reduced in hepatocarcinoma tissue [35]. The high expression
of miR-223 in these patients might be caused by a compensation
regulation due to the proliferation of the cancer cells. In esophageal
carcinoma, miR-223 targets artemin, a tumor metastasis-related
gene, and inhibits the metastasis-associated migration [26]. There
is also report that reduced serum expression ofmiR-223was associ-
ated with cancer-speciﬁc mortality in stage IA/B patients with non-
small cell lung cancer based on the survey of 220 patients [36].
Collectively, we demonstrated that transcription factor FOXO1
and its phosphorylation were down regulated by miR-223. In-
crease of unphosphorylated FOXO1 and its nuclear localization
suppress tumor cell proliferation via regulation of p21, p27, and
cyclin D1 gene transcription.
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